RE: Acute Leukaemia Screen
kukuruga%kasle1.dnet@rocdec.roc.wayne.edu
Thu, 25 May 95 09:15:34 -0400
Further response to Acute leuk. screening...
I would question the use of Ficoll separation on these specimins in any event.
Considering the assumed abnormality, and potentially rare, nature of the cells
analyzed, I worry over what I'm eliminating unknowingly. I think there is a
rapidly developing consensus re: immunophenotyping supporting whole blood
processing - not to mention the relative improvement in handling pathogen-
contaminated samples (okay, I will mention it).
MAK.
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories
and distributed free of charge as an educational service to the cytometry community.
If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL,
Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu
EMAIL robinson@flowcyt.cyto.purdue.edu